Varpaei Hesam Aldin, Bayraktar Nurhan, Mohammadi Mostafa
College of Nursing, Michigan State University, East Lansing, USA.
Atilim University School of Health Sciences, Nursing Department, Ankara, Turkiye.
Anesth Pain Med. 2023 Dec 12;13(6):e140847. doi: 10.5812/aapm-140847. eCollection 2023 Dec.
Non-invasive ventilation (NIV) is a method of oxygenation supply that eliminates the need for an endotracheal airway. Non-invasive ventilation failure is defined as the necessity for endotracheal intubation or death during the NIV trial.
This study aimed to identify the predictors and associated factors of NIV failure in coronavirus disease 2019 (COVID-19) patients admitted to an intensive care unit (ICU).
This retrospective, longitudinal cohort study utilized electronic medical records of COVID-19 patients admitted to the ICU. A total of 150 patients were included in the study. Patient demographics, medical history, laboratory tests, partial pressure of carbon dioxide (PCO), oxygen saturation (SpO), heart rate, acidosis, consciousness, oxygenation, and respiratory rate (HACOR score), and the ratio of oxygen saturation (ROX) index (the SpO/fraction of inspired oxygen [FIO] to respiratory rate [SF] ratio) were recorded. Non-invasive ventilation failure was determined based on the need for endotracheal intubation or cardiac-respiratory arrest while on NIV.
Of 150 patients, 55.3% were male (mean age: 55.9 years), with an NIV failure rate of 67.3%, a mortality rate of 66.7%, and 3.3% of patients requiring tracheostomy after NIV failure. The ROX index consistently decreased over time, and an increase in the HACOR score and PCO2 after 6 hours of commencing NIV were the predictors of NIV failure. Additionally, higher levels of lactate dehydrogenase, lower SF ratios, and higher APACHE scores upon ICU admission were significantly associated with NIV failure. Notably, the erythrocyte sedimentation rate (ESR) as an inflammatory index, SF ratio upon ICU admission, HACOR score, ROX index, and PCO2 after 12 hours were significant predictors of in-hospital mortality in patients receiving NIV.
The ROX index, HACOR scale, and PCO are significant predictors of both NIV failure and in-hospital mortality.
无创通气(NIV)是一种供氧方法,无需气管内插管。无创通气失败定义为在无创通气试验期间需要气管插管或死亡。
本研究旨在确定入住重症监护病房(ICU)的2019冠状病毒病(COVID-19)患者无创通气失败的预测因素及相关因素。
这项回顾性纵向队列研究利用了入住ICU的COVID-19患者的电子病历。共有150名患者纳入研究。记录患者的人口统计学资料、病史、实验室检查、二氧化碳分压(PCO)、血氧饱和度(SpO)、心率、酸中毒、意识、氧合及呼吸频率(HACOR评分),以及血氧饱和度比值(ROX)指数(SpO/吸入氧分数[FIO]与呼吸频率[SF]的比值)。无创通气失败根据在无创通气期间是否需要气管插管或心搏呼吸骤停来确定。
150例患者中,55.3%为男性(平均年龄:55.9岁),无创通气失败率为67.3%,死亡率为66.7%,3.3%的患者在无创通气失败后需要气管切开。ROX指数随时间持续下降,开始无创通气6小时后HACOR评分和PCO2升高是无创通气失败的预测因素。此外,入住ICU时较高的乳酸脱氢酶水平、较低的SF比值和较高的急性生理学与慢性健康状况评分系统(APACHE)评分与无创通气失败显著相关。值得注意的是,作为炎症指标的红细胞沉降率(ESR)、入住ICU时的SF比值、HACOR评分、ROX指数以及12小时后的PCO2是接受无创通气患者院内死亡的重要预测因素。
ROX指数、HACOR量表和PCO是无创通气失败和院内死亡的重要预测因素。